Clinical Trials Logo

Filter by:
NCT ID: NCT04312737 Completed - Neoplasms Clinical Trials

Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus

EU-VALHUDES
Start date: July 16, 2020
Phase:
Study type: Observational [Patient Registry]

The European VALHUDES study is a Clinical Performance /Diagnostic Test Accuracy Study that aims to evaluate whether HPV testing with new assays performed on self-samples, collected by means of a vaginal and a urine collection device is as accurate to detect cervical pre-cancer as on cliniciantaken cervical samples.

NCT ID: NCT04312503 Completed - Schizophrenia Clinical Trials

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

SWITCH
Start date: July 13, 2020
Phase:
Study type: Observational

The aim of this study is observation, in an Italian real-world setting, of metabolic effects in patients with schizophrenia who will switch from any mono-therapy or poly-therapy antipsychotic regimen to monotherapy with lurasidone or to one of the other four most used atypical antipsychotics.

NCT ID: NCT04312152 Enrolling by invitation - Clinical trials for Autism Spectrum Disorder

Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.

Q10ASD
Start date: March 9, 2019
Phase: N/A
Study type: Interventional

This double-blind, cross-over, randomized, controlled trial (RCT) has the aim of evaluating the effectiveness of a metabolic support therapy in two cohorts of patients with idiopathic Autism Spectrum Disorder or Phelan-McDermid syndrome, commonly associated with syndromic autism. Each patient will receive Q10 ubiquinol + Vit. E and B for 4 months and only Vit. E and B for 4 months in a double-blind, cross-over design. Primary outcome measures of efficacy include Vineland Adaptive Behavior Scales, Childhood Autism Rating Scale, Clinical Global Impression-Improvement and Visual Analog Scales; secondary outcome measures include several questionnaires and tests of autism, cognitive function, problem behaviors, quality of life, communication and comorbid disorders, as well as measures of oxidative stress.

NCT ID: NCT04311710 Terminated - Tumor Clinical Trials

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types

CheckMate 76U
Start date: June 25, 2020
Phase: Phase 1
Study type: Interventional

A study evaluating the drug levels of ipilimumab alone and in combination with nivolumab applied under the skin in various tumor types

NCT ID: NCT04310852 Recruiting - Knee Osteoarthritis Clinical Trials

Knee Osteoarthritis Treatment With Percutaneous Injections of Autologous Bone Marrow Concentrate

Bone-Gun
Start date: June 6, 2018
Phase:
Study type: Observational

Recently there has been a growing interest in the role of subchondral bone in knee arthritis, both in its etiology and evolution and in its clinical significance. It has now been widely demonstrated that changes in the subchondral bone can develop both as a cause and as a consequence of joint degeneration and it is now accepted in the scientific community that the presence of these changes is of clinical importance, causing pain and an inflammatory state that can contribute to the evolution of arthrosis arthropathy. Recently the use of mesenchymal cells obtained from the bone marrow has been proposed for the treatment of gonarthrosis by intra-articular injections. Even more recently, treatments have been studied and proposed for the treatment of the bone-cartilage interface in knees affected by osteoarthrosis, using autologous bone marrow concentrate, with promising results.

NCT ID: NCT04310670 Recruiting - Clinical trials for Functional Neurological Disorder

Integrated Treatment in FND (Functional Neurological Disorders)

FND
Start date: September 4, 2020
Phase: N/A
Study type: Interventional

The project will investigate the effectiveness of patient-centered integrated treatment. The correlations between physiotherapy indices, non-invasive brain stimulation, connectivity and psychological support will be analyzed.

NCT ID: NCT04310631 Completed - Coats Disease Clinical Trials

Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

Start date: January 1, 2016
Phase:
Study type: Observational

This study evaluates the retinal and vascular features in patients affected by Coats disease under the effects of Ranibizumab intravitreal injections using optical coherence tomography and optical coherence tomography angiography

NCT ID: NCT04310332 Completed - Colonoscopy Clinical Trials

1L- vs. 4L-PEG for Bowel Preparation Among Inpatients.

Start date: February 1, 2019
Phase:
Study type: Observational

Background and aims: Inpatients are at high risk for inadequate colon cleansing. Experts recommend 4L-polyethylene-glycol (PEG) solution because of its effectiveness and safety profile. A higher colon cleansing adequacy rate for a hyperosmolar 1L-PEG plus ascorbate prep has been recently reported in an observational study among more than 1,000 inpatients. Thus, the present study is aimed at determining whether 1L-PEG outperforms 4L-PEG among inpatients, through a propensity score-matching between the two groups in order to correct for confounders.

NCT ID: NCT04310176 Recruiting - Clinical trials for Ras-mutated Metastatic Colorectal Cancer

Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer

REVOLUTION
Start date: May 24, 2019
Phase: Phase 2
Study type: Interventional

The primary aim of this study is to test whether the combination of valproic acid with bevacizumab and oxaliplatin/fluoropyrimidine regimens (mFOLFOX6/mOXXEL) can prolong progression free survival (PFS) as compared with bevacizumab and oxaliplatin/fluoropyrimidine regimens alone as first-line treatment in patients with metastatic colorectal cancer with mutation of RAS.

NCT ID: NCT04309929 Completed - Breast Cancer Clinical Trials

Description of the Analgesia Obtained With the Anesthesiological Protocols Currently Used in Breast Surgery

Start date: September 12, 2016
Phase:
Study type: Observational

This study aims to describe the pain-relieving effect obtained with the current post-surgery pain control methods used in breast surgery by measuring the painful sensation and the consumption of opioids in the first 24 post-surgery hours. It also aims to describe the appearance of any complications such as post-surgery nausea and vomiting. Current anesthesia involves the combined use of intravenous painkillers and anti-inflammatory drugs such as acetaminophen, ketorolac, tramadol or morphine (the latter via PCA system = patient-controlled analgesia) or for local administration at the surgical site level ( local anesthetics). It is also proposed to describe the intensity and interference of pain in daily activities